(Q28269179)

5

object named as

Michel Bourin

0 references

author name string

Koen Demyttenaere

2

0 references

Zoltan Janka

3

0 references

Trond Aarre

4

0 references

Pier Luigi Canonico

6

0 references

Jose Luis Carrasco

7

0 references

Steven Stahl

Journal of Psychopharmacology

8

0 references

language of work or name

English

0 references

publication date

July 2007

0 references

published in

0 references

volume

21

0 references

issue

5

0 references

page(s)

461-71

0 references

cites work

Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Dose-effect relations in time-limited psychotherapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Treating organic abulia with bromocriptine and lisuride: four case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The influence of cognitive variables on recovery in depressed inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Ropinirole in treatment-resistant depression: a 16-week pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The neural circuitry of reward and its relevance to psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Bupropion in the management of apathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Bupropion sustained release treatment reduces fatigue in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The role of dopamine in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Role of 5-HT(2C) receptors in the control of central dopamine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Prefrontal cortical-amygdalar metabolism in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Pharmacology of amineptine: synthesis and updating

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The role of the limbic system in experiential phenomena of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Residual symptoms at remission from depression: impact on long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

A review of functional neuroimaging in mood disorders: positron emission tomography and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The cardiovascular effects of bupropion and nortriptyline in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Depressive illness and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Novel aspects of the chemical anatomy of the striatum and its efferents projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Milnacipran and selective serotonin reuptake inhibitors in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Cerebral perfusion in chronic fatigue syndrome and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Symptom-based predictors of a 10-year chronic course of treated depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Effect of continuation treatment on residual symptoms in late-life depression: how well is "well"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Onset of disability in depressed and non-depressed primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Dopaminergic-based pharmacotherapies for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Depression among high utilizers of medical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Empirical testing of two models for staging antidepressant treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Nucleus Accumbens Dopamine and the Regulation of Effort in Food-Seeking Behavior: Implications for Studies of Natural Motivation, Psychiatry, and Drug Abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Can recovery from depression be achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Efficacy of desipramine in endogenomorphically depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Symptom profiles of depression among general medical service users compared with specialty mental health service users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Assessing the effects of bupropion SR on mood dimensions of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

A doubleblind controlled trial of amineptine versus trimipramine in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Relationship between subjective effects of cocaine and dopamine transporter occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Toward a consensual structure of mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

Dopamine and depression: A review of recent evidence. I. Empirical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106069938

21 January 2018

Identifiers

DOI

10.1177/0269881106069938

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17050654

1 reference

Consolidated OpenCitations Corpus – April 2017